Abdulkadyrov Km
National Medical Research Center for Hematology(RU)Russian Research Institute of Hematology and Transfusiology(RU)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Legal and Regulatory Analysis, Military Technology and Strategies, Linguistic, Cultural, and Literary Studies, Acute Myeloid Leukemia Research
Most-Cited Works
- → Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma(2008)1,900 cited
- → Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial(2010)433 cited
- → Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies(2002)309 cited
- → Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma(2012)265 cited
- → Sotatercept in patients with osteolytic lesions of multiple myeloma(2014)124 cited
- → Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial